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Abstract
Background: Prolonged alcohol consumption is a significant co-factor in the progression of chronic viral infections
including hepatitis C and HIV, which are both single-stranded RNA viruses. Toll like receptor 8 (TLR8), a pattern
recognition receptor expressed in monocytes, senses viral single stranded RNA as a danger signal and leads to the
induction of Type I interferon (IFN) as well as the pro-inflammatory cytokine, tumor necrosis factor alpha (TNF
alpha). Lipopolysaccharide (LPS), a Toll like receptor 4 (TLR4) ligand, was shown to affect inflammatory cell
activation after alcohol consumption and in HIV and HCV infections. Here we hypothesized that alcohol exposure
modulates TLR8- and TLR4-ligand-induced monocyte activation and affects both type I IFN and inflammatory
cytokine induction.
Results: The TLR8 ligand, CL075, as well as the TLR4 ligand, LPS, resulted in a significant induction of TNF alpha
both at the mRNA and protein levels in human monocytes. We found that both acute and prolonged alcohol
treatment resulted in inhibition of type I IFN induction by either TLR8 or TLR4 ligands in human monocytes at the
protein and mRNA levels. In contrast to Type I IFN production, the effects of acute and prolonged alcohol were
different on inflammatory cytokine activation after TLR8 or TLR4 ligand stimulation. Acute alcohol inhibited TLR8-
or TLR4-induced TNF alpha protein and mRNA induction while it augmented IL-10 production in monocytes. In
contrast, prolonged alcohol treatment augmented TNF alpha without affecting IL-10 production significantly in
response to either TLR8 or TLR4 ligand stimulation.
Conclusions: These novel results suggest first, that alcohol has a profound inhibitory effect on Type I IFN induction
regardless of intracellular (TLR8) or cell surface-derived (TLR4) danger signals. Second, both acute and prolonged
alcohol exposure can inhibit antiviral Type I IFN pathway activation. Third, the opposite effects of acute (inhibitory)
and prolonged alcohol (augmentation) treatment on pro-inflammatory cytokine activation extend to TLR8-induced
signals beyond the previously shown TLR4/LPS pathway.
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Background
The immunoregulatory effects of acute and chronic
alcohol use have been linked to negative clinical out-
comes including prolonged recovery after trauma or
burn injury, elective surgery, liver disease and infections
[1-4]. Excessive alcohol consumption was also identified
as an independent risk factor in hepatitis C virus (HCV)
infection that leads to chronic infection in up to 80% of
cases [5,6]. Excessive alcohol use also affects outcomes
in HIV infection and predisposes to advanced disease
[7,8]. Both HCV and HIV are single-stranded RNA
viruses that induce anti-viral innate immune responses
via host pathways that recognize the viral “danger sig-
nals” [9-11]. Toll-like receptor 8 (TLR8) can sense
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and triggers downstream signaling to induce production
of Type I IFNs and pro-inflammatory cytokines [12-14].
TLR8 is expressed in monocytes and macrophages and
it is localized intracellularly in the endosomes where it
is positioned to be expose to viral danger signals [15].
Limited numbers of previous studies evaluated the
effects of alcohol on virus-induced immune responses
and mostly showed decreased antiviral immune
responses [4,16-18]. In hepatoma cells, alcohol was
shown to affect innate antiviral pathways and increase
HCV replication in human liver cells [19]. The effects of
alcohol exposure on anti-viral immune responses are yet
to be delineated in human immune cells that contribute
to the production of both Type I IFNs and inflammatory
cytokines [9].
In addition to viral danger signals, gut-derived lipopo-
lysaccharide (LPS), a ligand of Toll like receptor 4
(TLR4), has been shown to play a role in HIV and HCV
infection as well as in complications of chronic alcohol
exposure [20-22]. It has been shown that serum/plasma
LPS levels are elevated in patients with untreated HIV
infection and a moderate increase in serum LPS was
also reported in patients with chronic HCV infection
[23,24]. It has been postulated that the source of the cir-
culating LPS is the gut due to increased gut permeability
[23]. Increased gut permeability and an increase in cir-
culating LPS levels are the central components in the
pathogenesis of alcoholic hepatitis [25,26]. Thus, LPS/
TLR4 stimulation has direct clinical relevance to HIV
and HCV as well as alcohol consumption.
The effects of alcohol on LPS/TLR4 signaling were
evaluated in numerous previous studies, however, the
effects of alcohol on TLR4-induced IFN responses are
yet to be defined. Here, we tested the hypothesis that
acute and prolonged alcohol exposures modulate pro-
inflammatory cytokines as well as Type I IFN induction
in response to TLR8 or TLR4 ligand stimulation.
Results
TLR8- and TLR4-induced Type I IFN production is
inhibited by acute and prolonged alcohol treatment in
human monocytes
Innate immune responses by circulating monocytes and
tissue macrophages are triggered by viral and bacterial
danger signals to induce Type I IFNs and inflammatory
cascade activation [4,17]. TLR8, expressed in the endo-
some senses single-stranded RNA while TLR4,
expressed on the cell membrane is activated by bacterial
lipopolysaccharide [27]. Here we tested the hypothesis
that alcohol interferes with Type I IFN production in
response to viral or bacterial pathogen-derived signals.
Human peripheral blood monocytes were stimulated
with a TLR8 or TLR4 ligand in the presence or absence
of 25 mM alcohol. This in vitro treatment represents
acute alcohol exposure inh u m a n sa s2 5m Ma l c o h o l
approximates 0.1 g/dl blood alcohol level often found
after consumption of 4-5 drinks in non-alcoholic indivi-
duals [28]. Monocyte stimulation with CL075 (TLR8
ligand) or LPS (TLR4 ligand) resulted in a significant
increase in IFNb production at 6 hours after stimulation
while alcohol treatment alone did not affect baseline
IFNb production (Figure 1). Acute alcohol treatment
during the TLR8 and TLR4 stimulation resulted in a
decreasing trend in IFNb production in monocytes but
this did not reach statistical significance (Figure 1).
Considering that chronic alcohol consumption in
humans often involves sustained alcohol exposure, we
next evaluated the effects of prolonged alcohol treat-
ment on IFNb production. Monocytes were exposed to
25 mM alcohol for 7 days followed by TLR8 and TLR4
ligand stimulation. The alcohol concentration in the
supernatant was measured using the Analox Alcohol
Analyzer (Analox Instruments) and ranged from 23 mM
to 21 mM over the 7-day period (Additional file 1,
Table S1). This result is in accordance with our previous
study where we reported that alcohol concentrations
vary between 24 to 20 mM [28]. To rule out the possibi-
lity that prolonged alcohol treatment has any adverse
effect on cell viability, we performed an MTT assay
(Promega) and found no difference in the viability of
alcohol -naïve and -treated cells as shown in Additional
file 2, Figure S1. Recently, it has been shown that alco-
hol (25 mM) does not influence the human peripheral
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Figure 1 Decreased IFNb levels in monocytes stimulated with
acute alcohol and TLR8 or TLR4 ligand. Human monocytes (n =
3) were isolated as described in the methods. Cells were either
treated or not with 25 mM ethanol or 2.5 ug/ml CL075 (TLR8
ligand) or 0.1 ug/ml LPS (TLR4 ligand) for 6 hours. Some cells were
stimulated with a combination of 25 mM ethanol and 2.5 ug/ml
CL075 or 25 mM ethanol and 0.1 ug/ml LPS. The cell-free
supernatants were collected and IFNb production was measured by
ELISA. Error bars represent ± SEM. unst: unstimulated, ns: non
significant.
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Page 2 of 11mononuclear cells viability when either incubated for 24
hours or 48 hours and our results support this finding
[29].
Here we found that prolonged alcohol treatment alone
did not have any affect on baseline IFNb production
(Figure 2A and 2B). However, we found significant
attenuation of both TLR8- and TLR4-induced IFNb pro-
duction in prolonged alcohol-treated monocytes at 6
hours (Figure 2A). Inhibition of IFNb production was
sustained in TLR4-stimulated cells even after 24 hours
(Figure 2B). These data suggested that in the presence
of prolonged alcohol treatment, IFNb production is
decreased in monocytes whether induced by TLR8 or
TLR4 stimulation. To further assess the mechanisms of
alcohol-induced inhibition of IFNb production, we eval-
uated the mRNA levels of IFNb and found that both
TLR8 and TLR4-induced IFNb mRNA levels were
decreased in monocytes after prolonged alcohol treat-
ment (Figure 2C). These data suggested that prolonged
alcohol treatment inhibits type I IFN induction via
TLR8 or TLR4 mediated pathways and affects IFNb
mRNA levels. We also evaluated the affect of alcohol on
TLR8 (CL075) and TLR4 (LPS) receptors and found no
significant differences in alcohol-exposed cells (1 or 7
days) both at mRNA (data not shown) or protein levels
(Additional file 3, Table S2). This was consistent with
o u rp r e v i o u sf i n d i n gw h e r ew es h o w e dt h a ta l c o h o lh a s
no effect on TLR4 expression [28]. This data indicates
that alcohol doesn’t interfere with receptor expression
but might exert its effects on downstream signaling
pathways.
Induction of TNF alpha via TLR8 or TLR4 stimulation is
inhibited by acute but enhanced by prolonged alcohol
treatment
Blood monocytes contribute to systemic immune
responses and represent the source of inflammatory
cells recruited to different tissue sites. Here we tested
the hypothesis that acute and chronic alcohol regulates
the monocyte cytokine production profile in response to
TLR8 or TLR4 stimulation. Both LPS, a TLR4 ligand,
and CL075, a TLR8 ligand, induced production of the
pro-inflammatory cytokine TNF alpha in monocytes iso-
lated from healthy volunteers (Figure 3). We found that
co-administration of alcohol as an acute alcohol chal-
lenge with TLR8 or TLR4 ligand resulted in a significant
inhibition of TNF alpha production (Figure 3). This was
consistent with previous studies from our and other
laboratories on inhibition of LPS-induced TNF alpha
induction by acute alcohol both in vitro and in vivo
[28,30-32].
Next, monocytes were exposed to alcohol for 7 days at
a physiologically relevant concentration (25 mM), which
had no adverse effects on cell viability (Additional file 2,
Figure S1). Chronic alcohol treatment alone induced
minimal but statistically significant TNF alpha produc-
tion and robust TNF alpha production was elicited at 6
or 24 hours by TLR8 or TLR4 stimulation (Figure 4A
and 4B). In contrast to the effects of acute alcohol, pro-
longed alcohol treatment significantly augmented both
TLR8 and TLR4-induced production of TNF alpha in
human monocytes (Figure 4A and 4B). The increase in
TNF alpha protein was mirrored by the mRNA upregu-
lation in monocytes after 7 days of alcohol treatment in
response to TLR8 or TLR4 stimulation compared to
alcohol naïve cells (Figure 4C).
The anti-inflammatory cytokine, IL-10, is increased by
acute alcohol in response to TLR8 or TLR4 stimulation
Pro-inflammatory cytokine production, such as TNF
alpha, is counterbalanced by IL-10 induction, an anti-
inflammatory cytokine in monocytes [33]. Here we
found that acute alcohol treatment significantly upregu-
lated TLR8 and TLR4-induced IL-10 production in
human monocytes (Figure 5). The increased IL-10 pro-
duction in acute alcohol exposed monocytes was consis-
tent with the attenuation of TLR8 and TLR4-induced
TNF alpha production (Figure 3). This result suggests
t h er o l eo fI L - 1 0i nt h ea t t e n u a t i o no fT L R 8 -o rT L R 4 -
induced TNF alpha after acute alcohol treatment.
Finally, we assessed IL-10 production after prolonged
alcohol treatment. While there was a slight tendency for
increases in IL-10, there was no significant change in
TLR8 or TLR4-induced IL-10 production at the protein
(Figure 6A and 6B) or mRNA levels (Figure 6C) in alco-
hol treated cells.
Discussion
The immunomodulatory effects of alcohol use have been
described in various clinical settings including bacterial
and viral infections as well as in post-trauma and post-
surgical recoveries [2-4,34]. Increased activation of the
inflammatory cascade was found in chronic alcoholics
with liver disease where blood monocytes produced
increased levels of the pro-inflammatory cytokine TNF
alpha [35,36]. While inflammatory cytokine activation
has been investigated in several conditions related to
alcohol consumption, little is known about the effects of
alcohol on the induction of anti-viral immune
mediators.
In this study, we investigated the effects of acute and
prolonged alcohol on human monocyte responses to
TLR8 and TLR4 ligand stimulation and evaluated anti-
viral (Type I IFNs), pro- (TNF alpha) and anti-inflam-
matory (IL-10) cytokine production. Our novel data
indicate that IFNb production in response to TLR8 or
TLR4 stimulation was significantly attenuated in mono-
cytes exposed to alcohol. These data suggest that
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Figure 2 Prolonged alcohol exposure down regulates TLR8- or TLR4- induced IFNb expression both at protein and mRNA levels.
Human monocytes (n = 5 or 6) were either treated or not with 25 mM ethanol for 7 days, 2.5 ug/ml CL075 or 0.1 ug/ml LPS for 6 or 24 hours
and alcohol treated cells were further stimulated or not with CL075 or LPS for 6 hours (A and C) or 24 hours (B). The cell-free supernatants were
collected and analyzed for IFNb production by ELISA (A and B, n = 6). Total RNA was extracted from the cells and real time PCR was performed
to quantify the IFNb gene expression (C, n = 5). Error bars represent ± SEM. unst: unstimulated, ns: non significant.
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Page 4 of 11alcohol, regardless of the length of exposure, has inhibi-
tory effects on Type I IFN production in monocytes.
Our data further demonstrate that the effects of pro-
longed alcohol are opposite on Type I IFN induction
and inflammatory cytokine induction within the same
cell type. Prolonged alcohol exposure inhibited IFNb
production while it increased TLR8- and TLR4-induced
TNF alpha production. Finally, we show that the pre-
viously described anti-inflammatory effect of acute alco-
hol on TNF alpha production extends to TLR8-induced
TNF alpha induction and involves simultaneous induc-
tion of the anti-inflammatory cytokine, IL-10, in human
monocytes.
Toll-like receptors are evolutionarily preserved recep-
tors for recognition of danger signals [37]. Nucleic acid
sequences in viruses are recognized by TLRs expressed
in the endosome including TLR7 and TLR8 that sense
single-stranded RNA and TLR9 that sense bacterial
DNA [27]. LPS, a component of gram-negative bacteria,
activates TLR4 expressed on the cell surface [27].
Human monocytes express a broad repertoire of func-
tionally active TLRs including TLR8 and TLR4 [9,27].
We found that TLR8 or TLR4 ligand stimulation
resulted in the induction of both IFNb and inflamma-
tory cytokines in human blood monocytes. Ligand acti-
vation of TLR8 recruits MyD88, a common TLR
adapter, and triggers activation of IRAK1/4 kinases and
the TRAF6/TAK1 complex leading to the activation of
the IKK kinase complex that in turn induces inflamma-
tory cytokines, TNF alpha or IL-10 or phosphorylation
of IRFs that induce production of Type I IFNs [38].
TLR4 signaling involves recruitment of the adaptor
molecules MyD88 and/or TRIF, each activating different
downstream pathways to induce inflammatory cytokines
via NF-B or Type I IFNs via IRF activation, respectively
[38]. Considering the differences between the TLR8- and
TLR4-induced signaling, our data suggest that alcohol
likely modulates multiple components of these signal
transduction pathways. Indeed, modulation of NF-Bb y
acute and chronic alcohol has been extensively studied
in the past in LPS-stimulated monocytes [28,39].
The inhibitory effect of alcohol on Type I IFN induc-
tion is likely to be a clinically significant finding consid-
ering the large number of studies that demonstrate a
clinical correlation between alcohol use and impaired
anti-viral immune mechanisms [3,17,18,40,41]. Excessive
alcohol consumption is known to predispose individuals
to secondary infections such as HCV, HIV and bacterial
infections [5-7,20]. We found that the inhibitory effects
of alcohol occurred both at the IFNb protein and
mRNA levels. As we found no significant changes in
TLR8 and TLR4 mRNA or protein after alcohol treat-
ment, we speculate that alcohol interferes with some of
the intracellular signaling elements required for IFNb
gene induction in monocytes. Recently, Zhao et al have
described the role of PPAR-gamma in limiting IFNb
production via targeting IRF3 in macrophages [42]. In
line with this report, alcohol has been shown to activate
PPAR-gamma in rats [43] and mice [44].
Previous studies from our and other laboratories
showed that IFN-induced signaling pathways are also
inhibited by alcohol in blood monocytes as well as in
liver cells [19,39,45-47]. Phosphorylation of STAT-1 and
STAT-3 was inhibited by acute alcohol suggesting not
only IFNb production but even Type I IFN-induced
downstream events could be impaired by alcohol expo-
sure [39]. Recently, we showed that chronic alcohol
upregulates microRNA (miRNA)-155 in macrophages
[48] therefore, it is reasonable to argue that alcohol
might be targeting other miRNAs to limit IFNb
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Figure 3 Acute alcohol treatment down regulates TLR8- or TLR4- induced TNF alpha production. Human monocytes (n = 3) were either
treated or not with 25 mM ethanol or 2.5 ug/ml CL075 (TLR8 ligand) or 0.1 ug/ml LPS (TLR4 ligand) for 6 hours. Some cells were stimulated
with a combination of 25 mM ethanol and 2.5 ug/ml CL075 or 25 mM ethanol and 0.1 ug/ml LPS. The cell-free supernatants were collected and
TNF alpha production was measured by ELISA. Error bars represent ± SEM. unst: unstimulated.
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Figure 4 Prolonged alcohol exposure augments TLR8 or TLR4 induced TNF alpha expression. Human monocytes (n = 6 or 7) were either
treated or not with 25 mM ethanol for 7 days, 2.5 ug/ml CL075 or 0.1 ug/ml LPS for 6 or 24 hours and alcohol treated cells were further
stimulated or not with CL075 or LPS for 6 hours (A and C) or 24 hours (B). The cell-free supernatants were collected and analyzed for TNF alpha
production by ELISA (A and B, n = 6). RNA was extracted from the cells and real time PCR was performed to quantify TNF alpha gene expression
(C, n = 5). Error bars represent ± SEM. unst: unstimulated.
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Page 6 of 11production. In fact, miR-26a, -34a, -145, and let-7b are
shown to directly regulate IFNb in human and macaque
cells [49].
We found that acute and prolonged alcohol had oppo-
site effects on both TLR8- and TLR4-induced TNF
alpha production in human monocytes. Our laboratory
has extensively studied the opposite effects of acute and
prolonged alcohol on TLR4-mediated signaling pathways
and identified IRAK-M, IRAK1, IKK phosphorylation
and NF-B activation as common targets of acute and
chronic alcohol with opposite effects.
We showed that the inhibitory effects of acute alcohol
are mediated by alcohol- induced inhibition of NF-B
activation due to decreased phosphorylation of IKKa
and IKKb in LPS-stimulated human monocytes [50].
Based on this information and the fact that TNF alpha
induction involves NF-B activation whether induced
via TLR8 or TLR4, our observation of decreased TNF
alpha in acute alcohol-exposed TLR8 stimulated mono-
cytes suggests that NF-B inhibition is a likely mechan-
ism for inhibition of TLR8- induced TNF alpha
induction by acute alcohol. An additional mechanism
that likely contributes to decreased TNF alpha produc-
tion after acute alcohol is the increased induction of IL-
10 observed in TLR8 or TLR4 stimulated alcohol-
exposed monocytes in our experiments. The increased
TNF alpha induction by TLR8 ligand in chronic alco-
hol-exposed monocytes might involve NF-B activation
and reduced IRAK-M by chronic alcohol is also permis-
sive to increase TNF alpha production [28]. Finally,
induction of miR-155 after chronic alcohol treatment
results in increased TNF alpha production via increasing
TNF alpha mRNA stability [48], which is likely the
mechanism not only for TLR4- but also TLR8-induced
TNF alpha production in monocytes.
Lastly, alcohol treatment (acute or chronic) modu-
lates cytokines that negatively regulate TNF alpha. Pre-
vious studies from our laboratory demonstrated that
acute alcohol increases IL-10, TGFb and IL-13 produc-
tion in human monocytes [51-53]. In a mouse model,
acute alcohol has been shown to inhibit TLR- induced
inflammatory responses via the p38 and ERK1/2 path-
way [54]. While our or others studies found no
obvious decrease in the level of anti-inflammatory
cytokines after prolonged alcohol exposure in mono-
cytes or in vivo, there is an obvious imbalance between
pro- and anti-inflammatory cytokines with the pre-
sence of increased TNF alpha and no increase in IL-10
in human monocytes after prolonged alcohol treat-
ment. Thus, it is possible that prolonged alcohol expo-
sure targets multiple signaling molecules to augment
TNF alpha expression.
Conclusions
In summary, to our best knowledge, our data show for
the first time that alcohol modulates TLR8-induced
monocyte functions both at the level of anti-viral and
inflammatory mediator production. Our observations
suggest that alcohol exposure, whether acute or pro-
longed, impairs Type I IFN responses to viral and
bacterial PAMPs. The reduced Type I IFN production
occurs in the face of increased pro-inflammatory
(TNF alpha) cytokine production in monocytes with
chronic alcohol exposure suggesting that prolonged
alcohol changes the immune balance of monocyte
activation.
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Figure 5 Acute alcohol exposure augments TLR8- or TLR4- induced IL-10 expression. Human monocytes (n = 3) were either treated or
not with 25 mM ethanol or 2.5 ug/ml CL075 (TLR8 ligand) or 0.1 ug/ml LPS (TLR4 ligand) for 6 hours. Some cells were stimulated with a
combination of 25 mM ethanol and 2.5 ug/ml CL075 or 25 mM ethanol and 0.1 ug/ml LPS. The cell-free culture supernatants were collected
and IL-10 production was measured by ELISA. Error bars represent ± SEM. unst: unstimulated.
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Human monocyte isolation and reagents
Blood was collected from healthy individuals and mono-
cytes were isolated by the adherence method as
described previously [28]. The selection criteria for the
individuals signed up for this study was the same as
mentioned in our previous study [28] and is approved
by the “Institutional Review Board” (IRB), which is
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Figure 6 No significant changes in IL-10 expression after prolonged alcohol treatment.H u m a nm o n o c y t e s( n=6o r7 )w e r ee i t h e r
treated or not with 25 mM ethanol for 7 days, 2.5 ug/ml CL075 or 0.1 ug/ml LPS for 6 or 24 hours and alcohol treated cells were further
stimulated or not with CL075 or LPS for 6 hours (A and C) or 24 hours (B). The cell free supernatants were collected and analyzed for IL-10 alpha
production by ELISA (A and B, n = 6 or 7). RNA was extracted from the cells and real time PCR was performed to quantify IL-10 gene expression
(C, n = 5). Error bars represent ± SEM. unst: unstimulated. ns: non significant.
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Page 8 of 11called the “Committee for the Protection of Human
Subjects in Research” at UMMS. LPS and CL075 were
purchased from Sigma-Aldrich and Invivogen respec-
tively. Of note, CL075 mainly induces TLR8, however at
high concentrations it can also induce TLR7. The possi-
bility of TLR7 induction in our study is very minimal as
monocytes mainly express TLR8 and the concentration
of CL075 that we have used in our experiments is very
low. Elisa kits for IFNb (cat # GL80905), TNF alpha (cat
# 555212) and IL-10 (Cat # 88-7106) were purchased
from Fujirebio Inc, BD Biosciences and eBioscience
respectively.
Cells stimulation
The cells were cultured in 10% IMDM with MEM sup-
plements at 1 × 10
6 cell/ml. The serum was obtained
from HyClone and its endotoxin level was less than 0.06
EU/ml. Cells were stimulated with 25 mM ethanol for 6
hours (acute) or for 7 days (prolonged) and later chal-
lenged or not with 2.5 ug/ml CL075 or 0.1 ug/ml LPS
for 6 hours or 24 hours as indicated in the figure
legends. For prolonged alcohol treatment (7 days), the
cells were incubated in a C.B.S. Scientific chamber with
double the alcohol concentration in the bottom of the
chamber (to saturate the chamber) and on day 3 or 5,
half of the medium was replaced with fresh medium
containing alcohol as described previously [28].
Alcohol concentration in the cell-free supernatants
was assessed using the Analox Alcohol Analyzer (Ana-
lox Instruments).
Cell viability
Cell viability was checked with an MTT assay (Promega)
as per manufacturer’s recommendations. Briefly, cells at
1×1 0
6 cells/ml were grown in a 96 well plate and trea-
ted or not with 25 mM alcohol for indicated times. 15
μl of MTT dye solution was added and incubated at 37°
C for ~2 hours in a humidified 5% CO2 incubator. After
incubation, 100μl of solubilization solution was added
and the optical density was measured at 550nm with a
reference wavelength of 650nm in a microplate reader
(Labsystems). The percentage cell viability was calcu-
lated as mean OD of treated cells/mean OD of non-
treated cells *100.
RNA analysis
RNA was isolated with the RNeasy mini kit (Qiagen)
and cDNA synthesis was carried out using the Quanti-
Tect transcription kit (Qiagen). The quality of isolated
RNA was assessed by spectrophotometric method. Real
time PCR was performed (Bio Rad’s iCycler iQ real-time
detection system) to quantify the expression levels of
IFNb, TNF alpha and IL-10 using gene specific primers.
The Ct values were normalized to 18 s (internal control)
and fold change was calculated with reference to unsti-
mulated cells. The primers were synthesized from IDT
Inc (USA) and the specificity of each primer set was
determined by melt curve analysis. The primer
sequences were as follows: 18s, forward 5’-GTAAC
CCGTTGAACCCCATT-3’,r e v e r s e5 ’-CCATCCAAT
CGG TAGTAGCG-3’;T N F a,f o r w a r d5 ’-ATCTTCTC-
GAACCCCGAGTGA-3’,r e v e r s e5 ’- CGGTTCAGC-
CACTGGAGCT-3’, IL-10, forward 5’- AGACCCAGA
CATCAAGGC GCA-3’,r e v e r s e5 ’-ATCGATGA-
CAGCGCCGTAGCC-3’,I F N b,f o r w a r d5 ’-TCATA
TGCAGTACATTAGCCATCA -3’, reverse 5’-GATCTC
CTAGCCTGTGCCTC-3’.
ELISA
The amount of IFNb, TNF alpha and IL-10 in cell-free
supernatants was measured by ELISA as per manufac-
turer’s instructions.
Flow cytometry analysis
Isolated monocytes were rested for one day and next
day either stimulated or not with 25 mM alcohol for
indicated times. At the end of stimulation, cells were
used for staining using standard staining methods.
Briefly, cells were collected, washed and incubated with
fluorochrome-conjugated TLR4 (Biolegend, cat# 312805)
and CD14 or isotype control Abs at 4°C for 30min,
washed twice in PBS containing 2% FBS and fixed in 1%
paraformaldehyde. For TLR8 staining, cells were first
stained for cell surface CD14 protein and then permea-
bilized using a cell permeabilization kit (BD biosciences),
and incubated with TLR8 Ab (Imgenex, cat# IMG-
321C) and later fixed. Data was collected using a FACS-
can II flow cytometer (BD Biosciences), and analyzed
u s i n gF l o w J os o f t w a r e( T r e eS t a r ,I n c . ) .T h ef l u o r o -
chrome-conjugated Abs against human cell surface pro-
tein CD14 (cat# 555399) and isotype controls were
purchased from BD Pharmingen.
Statistical analysis
Statistical analysis was carried out by student t test (two
tailed) and p value less than 0.05 was considered
significant.
Additional material
Additional file 1: Table S1. Alcohol concentration in the supernatants
of cultured human monocytes.
Additional file 2: Figure S1. Alcohol treatment does not affect cell
viability. Human monocytes (n = 2) were either treated or not with 25
mM alcohol for indicated times in a 96 well plate at 1 × 10
6 cell/ml. Cell
viability was assessed by an MTT kit as per manufacture’s instruction and
optical density was measured at 550 nm with a reference wavelength of
650 nm. The percentage cell viability was calculated as mean OD of
Pang et al. BMC Immunology 2011, 12:55
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Page 9 of 11treated cells/mean OD of non-treated cells *100. Error bars represent
mean ± SEM. unst: unstimulated, ns: non significant.
Additional file 3: Table S2. Flow cytometric analysis of TLR4 and TLR8
proteins.
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